Text reads "Ascend T1D" with mountains and stars on a blue background
Media Release
Read more
New Study Compares ATG to Teplizumab, Aims to Expand Options to Delay Type 1 Diabetes
September 22, 2026 — Type 1 Diabetes TrialNet (TrialNet), the world’s leading international research network dedicated to type 1 diabetes prevention, has launched the ASCEND T1D Study.
Photo of TrialNet Chair Dr. Haller and Vice Chair Dr. Evans-Molina on a red background. Layered white text reads TrialNet leadership announcement.
Staff Spotlight
Read more
TrialNet Welcomes New Leaders at Pivotal Moment for Type 1 Diabetes Research
June 1, 2026 – Type 1 Diabetes TrialNet (TrialNet), the world’s leading international research network dedicated to the prevention of type 1 diabetes (T1D), today announced the appointment of Michael Haller, MD, as Chair and Carmella Evans-Molina, MD, PhD, as Vice Chair.
blue border on white background. TrialNet logo and text that reads TrialNet Leadership Announcement
Media Release
Read more
TrialNet Appoints New Leadership at Pivotal Moment for Type 1 Diabetes Research
June 1, 2026 – Type 1 Diabetes TrialNet (TrialNet), the world’s leading international research network dedicated to the prevention of type 1 diabetes, today announced the appointment of Michael Haller, MD, as Chair and Carmella Evans-Molina, MD, PhD, as Vice Chair.
Sign up here to join our mailing list for the latest updates on important T1D research and events, straight to your inbox. You can also find us on Facebook @DiabetesTrialNet.
